Target intelligence / Profile preview

Tissue proteins and cellular structures

Molecular classification
Other
01

Overview

Tissue proteins and cellular structures is a broad, non-specific designation used to describe the collective biological components of an organism that may interact with certain pharmacological agents. Unlike specific receptors or enzymes, this category includes a wide array of structural proteins, membrane lipids, and intracellular organelles that lack a single, defined binding site (Goodman & Gilman's The Pharmacological Basis of Therapeutics, 13th Ed). Drugs associated with this 'target' often exert their effects through non-specific mechanisms, such as the chemical modification of functional groups on various proteins or the alteration of physical properties of cellular membranes (NCBI Bookshelf, 'General Principles of Drug Action'). Examples include alkylating agents that bind to numerous cellular nucleophiles and general anesthetics that interact with various hydrophobic pockets in proteins and lipids (PubChem, 'Pharmacology and Toxicology'). Due to its lack of molecular specificity, it is not considered a valid therapeutic target for modern drug discovery and is often used as a placeholder for drugs with poorly characterized or multi-faceted mechanisms of action.

Other names
Cellular componentsStructural proteinsTissue-associated proteinsExtracellular matrix components
02

Mechanism of action

Non-specific covalent or non-covalent interaction with various cellular and extracellular components, including protein denaturation, alkylation, or physical-chemical partitioning.

03

Biological functions

Structural integrityCellular homeostasisMetabolic scaffolding
04

Disease associations

Other
05

Safety considerations

Lack of therapeutic indexSystemic toxicityOff-target effectsNon-selective tissue damage
06

Interacting drugs

Halothane

4 more in the full profile.

Beyond the preview

Go deeper on Tissue proteins and cellular structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue proteins and cellular structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call